SteadMed Signs Licensing, Distribution Agreement with PuriCore for Vashe Wound Therapy
SteadMed Medical, a provider of acute and chronic wound care products, announces it has signed an agreement with PuriCore, the water-based clean technology company, to market and distribute Vashe® Wound Therapy. Vashe Wound Therapy is a safe and effective non-antibiotic alternative treatment for acute and chronic wounds that is demonstrated to be extremely gentle and hypoallergenic.
Under the terms of the multi-year agreement, SteadMed will provide marketing and distribution services for Vashe in the United States, Canada, and Mexico, and will target hospitals, wound care centers, nursing homes, and home health agencies.
Vashe Wound Therapy is an excellent addition to our portfolio of products that are specifically selected to address growing patient needs in acute and chronic wound care, said Michael Steadman, president and chief executive officer for SteadMed Medical. We believe in marketing the highest quality products available, positioned as comprehensive solutions to healthcare practitioners and to the patients they treat. Vashe Wound Therapy is a welcomed and much-needed product for the millions of patients who suffer with acute and chronic wounds.
Available by prescription only, Vashe Wound Therapy is intended for use in cleansing, irrigating, moistening and debriding acute and chronic dermal lesions, including Stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, post-surgical wounds, first- and second-degree burns, abrasions, and minor irritations of the skin. Vashe Wound Therapy has been rigorously safety tested and is non-cytotoxic,
non-irritating and non-sensitizing. It has no oral toxicity or clinical contraindications for use.
This agreement expands PuriCores reach through SteadMeds experienced sales, marketing, and clinical teams, while enhancing SteadMeds already strong wound care portfolio in the North American wound care market, says Michael Ashton, executive chairman of PuriCore.
Source: SteadMed Medical
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
